Stocks & Investing
Stocks and Investing
Stocks and Investing
Fri, February 14, 2020
[ Fri, Feb 14th 2020
] - WOPRAI
[ Fri, Feb 14th 2020
] - WOPRAI
[ Fri, Feb 14th 2020
] - WOPRAI
[ Fri, Feb 14th 2020
] - WOPRAI
[ Fri, Feb 14th 2020
] - WOPRAI
[ Fri, Feb 14th 2020
] - WOPRAI
[ Fri, Feb 14th 2020
] - WOPRAI
[ Fri, Feb 14th 2020
] - WOPRAI
[ Fri, Feb 14th 2020
] - WOPRAI
[ Fri, Feb 14th 2020
] - WOPRAI
[ Fri, Feb 14th 2020
] - WOPRAI
[ Fri, Feb 14th 2020
] - WOPRAI
[ Fri, Feb 14th 2020
] - WOPRAI
[ Fri, Feb 14th 2020
] - WOPRAI
[ Fri, Feb 14th 2020
] - WOPRAI
[ Fri, Feb 14th 2020
] - WOPRAI
[ Fri, Feb 14th 2020
] - WOPRAI
[ Fri, Feb 14th 2020
] - WOPRAI
[ Fri, Feb 14th 2020
] - WOPRAI
[ Fri, Feb 14th 2020
] - WOPRAI
[ Fri, Feb 14th 2020
] - WOPRAI
[ Fri, Feb 14th 2020
] - WOPRAI
[ Fri, Feb 14th 2020
] - WOPRAI
[ Fri, Feb 14th 2020
] - WOPRAI
[ Fri, Feb 14th 2020
] - WOPRAI
[ Fri, Feb 14th 2020
] - WOPRAI
[ Fri, Feb 14th 2020
] - WOPRAI
[ Fri, Feb 14th 2020
] - WOPRAI
Robyn Karnauskas Maintained (BTAI) at Strong Buy with Increased Target to $150 on, Feb 14th, 2020
Robyn Karnauskas of SunTrust Robinson Humphrey, Maintained "BioXcel Therapeutics, Inc." (BTAI) at Strong Buy with Increased Target from $24 to $150 on, Feb 14th, 2020.
Robyn has made no other calls on BTAI in the last 4 months.
There is 1 other peer that has a rating on BTAI. Out of the 1 peers that are also analyzing BTAI, 0 agree with Robyn's Rating of Hold.
This is the rating of the analyst that currently disagrees with Robyn
- Raghuram Selvaraju of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $30 on, Wednesday, January 8th, 2020
Similar Stocks and Investing Articles
[ Mon, Feb 10th 2020
] - WOPRAI
[ Mon, Feb 10th 2020
] - WOPRAI
[ Mon, Feb 03rd 2020
] - WOPRAI
[ Fri, Jan 17th 2020
] - WOPRAI
[ Wed, Jan 08th 2020
] - WOPRAI
[ Mon, Dec 30th 2019
] - WOPRAI
[ Tue, Dec 17th 2019
] - WOPRAI
[ Fri, Jun 29th 2018
] - WOPRAI
[ Fri, Jan 26th 2018
] - WOPRAI
[ Tue, Apr 08th 2014
] - WOPRAI